MirvasO Soolantra Association In the Treatment of Moderate to Severe rosaCea.
Clinical trial NCT02616250 · COMPLETED
Trial details
- NCT number
- NCT02616250
- Sponsor
- Galderma R&D
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2015-12-01
- Primary completion
- 2016-09-01
- Enrollment
- 190
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.